Comparative Study of Antibacterial Activity of Nanosilver Synthesized Using Trigonosciadium brachytaenium (Boiss.) Alava Leaves Extract, Alone and Mixed with Gentamicin

authors:

avatar Shahrzad Raoufi 1 , avatar Ali Shafaghat 2 , *

Department of Phytochemistry, Pharmaceutical Sciences Branch, Islamic Azad University, Tehran, Iran
Department of Chemistry, Khalkhal Branch, Islamic Azad University, Khalkhal, Iran

How To Cite Raoufi S, Shafaghat A. Comparative Study of Antibacterial Activity of Nanosilver Synthesized Using Trigonosciadium brachytaenium (Boiss.) Alava Leaves Extract, Alone and Mixed with Gentamicin. Jundishapur J Nat Pharm Prod. 2018;13(3):e57241. https://doi.org/10.5812/jjnpp.57241.

Abstract

Background:

The phytosynthesis of Ag nanoparticles (AgNPs) by plant materials is emerging as an important branch of nanobiotechnology due to its eco-friendly, safe, and cost-effective nature. It also does not produce any noxious materials.

Objectives:

Nanophytosynthesis of AgNPs by the Trigonosciadium brachytaenium leaf extract and the investigation of its antimicrobial activity and physicochemical properties are reported.

Methods:

AgNPs were prepared by a nanophytosynthesis method. The structural and properties of the NPs were investigated by spectroscopy. The antimicrobial effect against seven bacterial species was studied according to the agar diffusion cup method.

Results:

The bioassay showed that the silver nanoparticles exhibited a good antimicrobial activity. The average particle size was found to be 32 - 33 nm.

Conclusions:

This study demonstrated the possible use of phytosynthesized AgNPs in the field of medicine. The approach of AgNPs phytofabrication with T. brachytaenium emerges to be very effective as an alternative to the common procedures of fabrication.

1. Background

Over the past several decades, modifying and safekeeping our environment using green chemistry have become an important topic in many fields of research (1). The nanotechnology has led to a growing feeling of excitation in the life sciences, especially in biomedical and biotechnology devices (2). Silver nanoparticles (AgNPs) have attracted much attention due to their applications in biosensing (3), their antimicrobial activity (4), catalysis (5), label-free colorimetric assay (6), biological imaging, medical diagnostics and therapeutics (7), to name a few, used in biomedical treatments (8) and in industry. Nanophytosynthesis of materials in a compatible method with the environment is a request for today sciences. Recent research has received significant attention and it offers many advantages towards the biological synthesis of AgNPs (9). The potential application of microorganisms and plant materials in AgNPs synthesis has been explored (10, 11). Some of the nanoparticles characterized a good potential antimicrobial activity and significantly higher synergistic effects when combined with many antibiotics (12). The interactions of silver nanoparticles with bacteria are belonging to the size and structure of the nanoparticles (13). The silver nanoparticles as antimicrobial functional agents have been applied extensively in different fields of medicine such as molecular imaging, recognition, and treatment of cardiovascular diseases and drug delivery (14, 15). The alcoholic extracts of plants, which contain bioactive compounds, have recently been used for NPs biological synthesis. Many different plant leaves and herbs have been used to produce nanoparticles (16). Green biotechnology has attracted much attention and it includes a wide range of processes that reduce or eliminate toxic compounds to restore the environment. It has a great potential with natural product reductants (17) such as bacteria, fungi, and plant extracts (18-20). The genus Trigonosciadium species (family: Umbelliferae) is endemic in Iran (21). No nanophytosynthesis studies on Trigonosciadium brachytaenium have been reported, but our previous study represented the presence of flavonoids, saponins, and tannins (22). The antimutagenic, anticarcinogenic, and cardioprotective effects of phenolic compounds are reported to be generally associated with their antioxidant activities by scavenging free radicals and alleviating lipid peroxidation (23).

2. Objectives

In the present study, we investigated the biosynthesis of AgNPs by the T. brachytaenium (Boiss.) Alava leaves extract for the first time and concluded the reasons for this synthesis. We also studied the antimicrobial activity of crude extract, biosynthesized AgNPs alone, and in combination with an antibiotic (Gentamycin) against some bacterial pathogens.

3. Methods

3.1. Materials

The leaves part of T. brachytaenium (Boiss.) Alava was collected in June 2014 from the Khalkhal area (Ardabil province) in the northwest of Iran at an altitude of 1950 m, and dried for 5 days at the room temperature. A voucher specimen (No. 028) was deposited at the Herbarium of the Agriculture Research at the Ardabil Center, Iran (source: the color flora of Iran, A. Ghahreman, No. 2248; COD, 091,074,001 (Figure 1)). Ethanol (C2H5OH, 96 %) and silver nitrate (AgNO3, 99.98%) were purchased from Merck (Germany) and solutions were prepared with double distilled water. Other chemical reagents used were of analytical grade.

Trigonosciadium brachytaenium (Boiss.) Alava
Trigonosciadium brachytaenium (Boiss.) Alava

3.2. Preparation of Plant Extract

The leaf parts of fresh T. brachytaenium were washed with distilled water and dried in the oven for 6 hours. Dried and finely powdered products (100 g) were exhaustively macerated with a hydroalcoholic (water and ethanol; 50: 50) solvent. The obtained extract was then kept in a dark vessel at 2°C until use.

3.3. Phyto-Assisted Synthesis of Silver Nanoparticle

For the preparation of silver nanoparticles (AgNPs), a five g portion of the raw extract of T. brachytaenium leaves were added to double distilled water and kept under vigorous shaking for about 60 minutes. This step was followed by the addition of 100 mL of a 0.5 M aqueous solution of silver nitrate (AgNO3). The resulting solution was blended at laboratory temperature (25°C) for 48 hours. The silver nitrate solution was used as a precursor in the synthesis process of Ag nanoparticle. AgNPs were gradually obtained during the incubation period. During the stirring step in the phytosynthesis procedure, a change in the mixture color was observable that was stable for about 5 to 10 minutes. The color changes indicated the production of silver nanoparticles. The AgNPs mixture obtained was subsequently purified by centrifugation at 3000 rpm for 25 minutes.

Color changes before (A) and after (B) the process of reduction of Ag+ to Ag NPs.
Color changes before (A) and after (B) the process of reduction of Ag+ to Ag NPs.

3.4. Characterization Methods and Instruments

For identifying the biomolecules composition responsible for the reduction of silver ions (Ag+) to AgNPs and their phytosynthesis by the plant hydroalcoholic extract, the FT-IR spectroscopy measurements were carried out. The AgNPs powder was prepared by centrifuging the synthesized Ag nanoparticles solutions at 2000 rpm for 25 minutes. UV-Vis spectra were generated for the analysis and characterization of AgNPs by a Perkin Elmer-Lambda 25 UV/Vis spectrophotometer. The analysis was conducted at room temperature and the apparatus was operated at a resolution of 1 nm from 250 to 800 nm. The X-ray diffraction (XRD) analysis of drop-coated films of AgNPs in the sample was accomplished for the determination of Ag nanoparticles formation by a Bruker, B8-advance, X-ray diffractometer operated at a voltage of 40 kv and a current of 30 mA with Cu Kα radiation. The diffracted intensities were recorded from 10 to 90° at 2θ angles. The size of the AgNPs was calculated using the Debye-Scherrer equation. TEM imaging was carried out using a Philips GM-30 electron microscope. The AgNPs size distribution was specified using the UTHSCSA image tool version 3.00 program. The SEM analysis was carried out using the LEO 1430 VP SEM machine operated at an accelerating voltage of 10 keV. EDX analysis was then conducted using the instrument thermo energy dispersive X-ray (EDX) analysis combined with SEM.

3.5. Antimicrobial Activity

The biological activity was examined against Bacillus subtilis ATCC 9372, Staphylococcus epidermidis ATCC 12228, Enterococcus faecalis ATCC 15753, Staphylococcus aureus ATCC 25923, Klebsiella pneumoniae ATCC 3583, Pseudomonas aeruginosa ATCC 27852, and Escherichia coli ATCC 25922. The antimicrobial activities of as prepared AgNPs were essayed against some human pathogenic bacteria using the disc diffusion method (24). To define the mixture effects, 6 mm sterile discs impregnated with 20 μL solutions of each sample were placed on freshly prepared Muller-Hinton Agar medium plates inoculated with bacterial cultures. These discs were placed on different areas of the plates and incubated at 37°C for 24 hours. A gentamicin disc was used as the positive control. The inhibition zones were measured and compared with the inhibition zone of the gentamycin disc as a standard positive control (Table 1).

Table 1.

Comparison of Antibacterial Activity of Crude Extract, Alone AgNPs Synthesized by Leaves Extract of Trigonosciadium brachytaenium, and in a Mixture with Gentamycin

Tested MicroorganismsZone of Inhibition (mm)a
Crude ExtractAgNPsGentamicinAgNPs + Gentamycin
Staphylococcus aureus11 ± 0.2715 ± 0.9513 ± 1.3119 ± 0.31
Klebsiella pneumoniaeNA13 ± 0.5514 ± 0.4316 ± 0.91
Bacillus subtilis12 ± 0.1517 ± 0.6016 ± 1.7318 ± 0.22
Staphylococcus epidermidis11 ± 0.8219 ± 0.1121 ± 0.4721 ± 0.79
Enterococcus faecalis8 ± 0.4615 ± 1.2114 ± 0.3617 ± 0.12
Escherichia coliNA13 ± 0.5512 ± 0.2917 ± 0.31
Pseudomonas aeruginosa10 ± 0.1916 ± 0.2313 ± 0.2120 ± 0.53

4. Results

The characterization of the nanoparticles is significant to understand and manage the nanoparticles synthesis and applications. In recent years, scientists have paid attention to the green synthesis and its use for the preparation of Ag nanoparticles by applying various plant materials in the nanophytosynthesis methods (25).

4.1. Nanophytosynthesis

The biosynthesis of AgNPs through plant extracts was carried out. AgNPs were synthesized from silver nitrate solutions containing silver cations (Ag+) by treating with the leaves extract of T. brachytaenium. By the reduction of silver cations (Ag+), the formation of stable silver nanoparticles started soon and continued through the reaction. Figure 2 shows the images of the T. brachytaenium leaves extract (photograph A) before combination and phytosynthesis reaction with AgNO3 and color changes within the conversion of Ag+ ions to Ag nanoparticles (photograph B). The appearance of a tawny brown color confirms the entity of silver nanoparticles in the flask (B). The Ultraviolet/Visible spectrophotometry measurement was used for identifying the possible secondary metabolites responsible for covering and effective stabilization of phytosynthesized AgNPs using the T. brachytaenium leaves extract. Figure 3B demonstrates the FT-IR spectrum of the leaves extract, which represents absorption bands at 3421, 2928, 1641, 1621, 1453, 1378, 1258, 1135, and 1057 cm-1. The peak at 1641 cm-1 accounts for the stretching vibration of C = O on the chromen-4-one rings of flavonoid derivatives. The peak at 3421 corresponds to N-H and O-H stretching vibrations of amides, alcohols, or H bonded to phenols.

A, Absorption peaks of silver nanoparticles using the extract of T. brachytaenium leaves under UV/Vis spectroscopy; B, FT-IR spectrum of Trigonosciadium brachytaenium leaves extract.
A, Absorption peaks of silver nanoparticles using the extract of T. brachytaenium leaves under UV/Vis spectroscopy; B, FT-IR spectrum of Trigonosciadium brachytaenium leaves extract.

The SEM determinations of the sample showed the formation of AgNPs, which were confirmed to be of silver by EDX. The SEM image represents relatively cubic and almost orbicular-shaped nanoparticle with a diameter of 44.2 nm (Figure 4A). As shown in Figure 4 (A and B), well-dispersed nanoparticles could be seen in the samples treated with silver nitrate. The analysis of EDX showed a signal in the Ag region, confirming the formation of AgNPs (Figure 4B). The morphology, crystalline nature, and the size of the obtained AgNPs were investigated and determined by transmission electron microscopy (TEM) images. The typical TEM image of as-biosynthesized silver nanoparticles is shown in Figure 4C, which indicates the formation of AgNPs. This image and the size distribution of AgNPs characterized that the mean diameter of the synthesized materials (AgNPs) was approximately within the range of 25 to 36 nm.

(A), SEM; (B), EDX; (C), TEM, analysis of AgNPs synthesized by Trigonosciadium brachytaenium leaves.
(A), SEM; (B), EDX; (C), TEM, analysis of AgNPs synthesized by Trigonosciadium brachytaenium leaves.

The X-ray diffraction (XRD) measurement was used to confirm the crystalline nature of AgNPs. The dry powders of the prepared Ag nanoparticles were used for the XRD analysis. The XRD diffraction patterns obtained for the AgNPs synthesized using the T. brachytaenium leaves extract are shown in Figure 5. The estimated average size of AgNPs was 32.7 nm derived from FWHM of the signal corresponding to 111 planes, identified by using the following equation:

XRD patterns of silver nanoparticle synthesized using Trigonosciadium brachytaenium leaves extract.
XRD patterns of silver nanoparticle synthesized using Trigonosciadium brachytaenium leaves extract.

4.2. Antibacterial Studies

In the present study, the antimicrobial activity of the T. brachytaenium extract, Ag nanoparticles (AgNPs) alone, and combined with antibiotic (gentamycin) using a novel biosynthetic method was assayed. In this analysis, the AgNPs synthesized by the T. brachytaenium leaves extract in combination with gentamycin showed good toxicity against resistant human pathogenic bacteria at the same concentration (5 μg/mL). All samples were tested against three Gram-negative and four Gram-positive bacteria and compared with gentamicin as the standard antibiotic at a concentration of 5 μg/mL. The results, presented in Table 1, showed that the AgNPs in a mixture with gentamycin exhibited more biological activity than standard antibiotic gentamicin against all the tested bacteria. The highest sensitive microorganisms were Bacillus subtilis, Staphylococcus aureus, Staphylococcus epidermidis, and Pseudomonas aeruginosa with the inhibition zones of 17, 19, 21, and 20 mm, respectively. Other microorganisms including Klebsiella pneumoniae, Enterococcus faecalis, and Escherichia coli were found also to be sensitive to the mixture of AgNPs and gentamycin with the inhibition zones 16, 17, and 17 mm, respectively (Table 1).

5. Discussion

The antibacterial resistance of pathogenic microorganisms such as bacteria and fungi has been continuously increasing over the past decade. Therefore, there is a need for the development of novel antimicrobial agents. In recent years, AgNPs have emerged as a promising antibacterial candidate in the medical fields (26). It is commonly documented that UV/Vis spectrophotometry could be used for testing the shape and size-controlled nanoparticles in aqueous suspensions (27).

The results obtained from UV/Vis spectroscopy showed this is an efficient technique to characterize the formation and stability of AgNPs. The absorbed peak at 380 to 450 nm in the UV/Vis spectrum and the broadening signal of the colloidal solutions of AgNPs indicated that the nanoparticles are poly-dispersed. Recently, chalcone and flavonoid derivatives with methoxy groups in the extract of T. brachytaenium as a major compound have shown to play a key role in the reduction and stability of AgNPs (22, 28). These kinds of flavonoid derivatives are known to act as potential reducing agents by donating free electrons (29). It is clear that the plant materials including flavonoid derivatives, glycosides, coumarins, phloroglucinols, anthraquinones, xanthones, flavonol glycosides, pyrones, lactones, triterpenes, lipids, tannins, and volatile oils act as reducing agents for the generation of metal nanoparticles (30, 31). Recent results with Capsicum annuum L. extract (32), Ginko biloba, Pinus desiflora, Magnolia kobus, Diopyros kaki, and Platanus orientalis leaves extracts (33) represented that the proteins that have amine groups as reducing agents play a controlling role during the formation of AgNPs in the aqua mixture, and the secondary structure of the proteins changed after the reaction with silver cations (Ag+). It has been reported that the changes observed in the membrane structure of the bacterial cell wall due to the action of AgNPs must be due to the interaction with embedded silver nanoparticles resulting in the increased membrane permeability and consequently, the death of the bacteria (34). It is also well determined that silver cation-based compounds have a strong antimicrobial activity. Elaborate investigations are more required to elucidate the mechanism of biological synthesis of the metal and the derivative nanoparticles.

In conclusion, silver nanoparticles can be synthesized using the hydroalcoholic extract of the leaves of T. brachytaenium as a plant source. This study determined that plant materials in the solvent extract are good sources for the phytosynthesis of nanosilver and some other metals. The extract of the leaves of T. brachytaenium was found suitable for the green biosynthesis of AgNPs. The bioreduction of Ag+ cations by the solvent extract of the leaves resulted in the formation of stable nanoparticles with nano dimensions. This method is eco-friendly and offers medicinal value to nanoparticles. The antibacterial activity against human pathogens confirmed that the silver nanoparticles could explain the antibacterial effect and strengthen the medicinal valuation of the plants. The AgNPs obtained in this study were produced quickly, suitably, and with a low cost. We believe that the nanophytosynthesis of AgNPs is most convenient and they are easily scaled up; moreover, the synthesis of these polyshaped AgNPs by the above compounds will definitely enhance their quality. Therefore, these nanoparticles can be very useful for application in products that come in direct human contacts such as cosmetics, foods, and medicine.

References

  • 1.

    Salata OV. Applications of nanoparticles in biology and medicine. J Nanobiotechnol. 2004;2(1):3. [PubMed ID: 15119954]. [PubMed Central ID: PMC419715]. https://doi.org/10.1186/1477-3155-2-3.

  • 2.

    Prabhu N, Raj DT, Yamuna GK, Ayisha SS, Puspha J, Innocent D. Synthesis of silver phyto nanoparticles and their antibacterial efficacy. Digest J Nanomater Biostruct (DJNB). 2010;5(1):185-9.

  • 3.

    Chen A, Chatterjee S. Nanomaterials based electrochemical sensors for biomedical applications. Chem Soc Rev. 2013;42(12):5425-38. [PubMed ID: 23508125]. https://doi.org/10.1039/c3cs35518g.

  • 4.

    Amato E, Diaz-Fernandez YA, Taglietti A, Pallavicini P, Pasotti L, Cucca L, et al. Synthesis, characterization and antibacterial activity against Gram positive and Gram negative bacteria of biomimetically coated silver nanoparticles. Langmuir. 2011;27(15):9165-73. [PubMed ID: 21736306]. https://doi.org/10.1021/la201200r.

  • 5.

    Shiraishi Y, Toshima N. Oxidation of ethylene catalyzed by colloidal dispersions of poly(sodium acrylate)-protected silver nanoclusters. Colloid Surfaces A Physicochem Engn Aspect. 2000;169(1-3):59-66. https://doi.org/10.1016/s0927-7757(00)00417-9.

  • 6.

    Wei H, Chen C, Han B, Wang E. Enzyme colorimetric assay using unmodified silver nanoparticles. Anal Chem. 2008;80(18):7051-5. [PubMed ID: 18662017]. https://doi.org/10.1021/ac801144t.

  • 7.

    El-Sayed IH, Huang X, El-Sayed MA. Surface plasmon resonance scattering and absorption of anti-EGFR antibody conjugated gold nanoparticles in cancer diagnostics: applications in oral cancer. Nano Lett. 2005;5(5):829-34. [PubMed ID: 15884879]. https://doi.org/10.1021/nl050074e.

  • 8.

    Arvizo RR, Bhattacharyya S, Kudgus RA, Giri K, Bhattacharya R, Mukherjee P. Intrinsic therapeutic applications of noble metal nanoparticles: past, present and future. Chem Soc Rev. 2012;41(7):2943-70. [PubMed ID: 22388295]. [PubMed Central ID: PMC3346960]. https://doi.org/10.1039/c2cs15355f.

  • 9.

    Lee KJ, Park SH, Govarthanan M, Hwang PH, Seo YS, Cho M, et al. Synthesis of silver nanoparticles using cow milk and their antifungal activity against phytopathogens. Mater Lett. 2013;105:128-31. https://doi.org/10.1016/j.matlet.2013.04.076.

  • 10.

    Shafaghat A. Synthesis and characterization of silver nanoparticles by phytosynthesis method and their biological activity. Synth React Inorg Met Org Chem. 2014;45(3):381-7. https://doi.org/10.1080/15533174.2013.819900.

  • 11.

    Sastry M, Ahmad A, Khan MI, Kumar R. Biosynthesis of metal nanoparticles using fungi and actinomycete. Curr Sci. 2003;85(2):162-70.

  • 12.

    Devi LS, Joshi SR. Antimicrobial and synergistic effects of silver nanoparticles synthesized using soil fungi of high altitudes of eastern himalaya. Mycobiology. 2012;40(1):27-34. [PubMed ID: 22783131]. [PubMed Central ID: PMC3385152]. https://doi.org/10.5941/MYCO.2012.40.1.027.

  • 13.

    Panacek A, Kvitek L, Prucek R, Kolar M, Vecerova R, Pizurova N, et al. Silver colloid nanoparticles: synthesis, characterization, and their antibacterial activity. J Phys Chem B. 2006;110(33):16248-53. [PubMed ID: 16913750]. https://doi.org/10.1021/jp063826h.

  • 14.

    Kohl Y, Kaiser C, Bost W, Stracke F, Fournelle M, Wischke C, et al. Preparation and biological evaluation of multifunctional PLGA-nanoparticles designed for photoacoustic imaging. Nanomedicine. 2011;7(2):228-37. [PubMed ID: 20732457]. https://doi.org/10.1016/j.nano.2010.07.006.

  • 15.

    Dar MA, Ingle A, Rai M. Enhanced antimicrobial activity of silver nanoparticles synthesized by Cryphonectria sp. evaluated singly and in combination with antibiotics. Nanomedicine. 2013;9(1):105-10. [PubMed ID: 22633901]. https://doi.org/10.1016/j.nano.2012.04.007.

  • 16.

    Karnani RL, Chowdhary A. Biosynthesis of silver nanoparticle by eco-friendly method. Indian J Nanosci. 2013;1(1):25-31.

  • 17.

    Sivalingam P, Antony JJ, Siva D, Achiraman S, Anbarasu K. Mangrove Streptomyces sp. BDUKAS10 as nanofactory for fabrication of bactericidal silver nanoparticles. Colloids Surf B Biointerfaces. 2012;98:12-7. [PubMed ID: 22652354]. https://doi.org/10.1016/j.colsurfb.2012.03.032.

  • 18.

    Niraimathi KL, Sudha V, Lavanya R, Brindha P. Biosynthesis of silver nanoparticles using Alternanthera sessilis (Linn.) extract and their antimicrobial, antioxidant activities. Colloids Surf B Biointerfaces. 2013;102:288-91. [PubMed ID: 23006568]. https://doi.org/10.1016/j.colsurfb.2012.08.041.

  • 19.

    Kalimuthu K, Suresh Babu R, Venkataraman D, Bilal M, Gurunathan S. Biosynthesis of silver nanocrystals by Bacillus licheniformis. Colloids Surf B Biointerfaces. 2008;65(1):150-3. [PubMed ID: 18406112]. https://doi.org/10.1016/j.colsurfb.2008.02.018.

  • 20.

    Ingle A, Gade A, Pierrat S, Sonnichsen C, Rai M. Mycosynthesis of silver nanoparticles using the fungus fusarium acuminatum and its activity against some human pathogenic bacteria. Curr Nanosci. 2008;4(2):141-4. https://doi.org/10.2174/157341308784340804.

  • 21.

    Mozaffarian V. [A Dictionary of Iranian Plant Names]. Tehran, Iran: Farhang Moaser Publishers; 2007. Persian.

  • 22.

    Akhavan M, Shafaghat A, Salimi F. Novel acetylated chalcone and biflavonoid glycosides from Trigonosciadium brachytaenium (Boiss.) Alava. Nat Prod Res. 2013;27(22):2111-7. [PubMed ID: 23631351]. https://doi.org/10.1080/14786419.2013.791822.

  • 23.

    Potter JD. Vegetables, fruit, and cancer. Lancet. 2005;366(9485):527-30. [PubMed ID: 16099275]. https://doi.org/10.1016/S0140-6736(05)67077-8.

  • 24.

    Bauer AW, Kirby WMM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966;45(4_ts):493-6. https://doi.org/10.1093/ajcp/45.4_ts.493.

  • 25.

    Muthukrishnan S, Bhakya S, Senthil Kumar T, Rao MV. Biosynthesis, characterization and antibacterial effect of plant-mediated silver nanoparticles using Ceropegia thwaitesii an endemic species. Ind Crops Prod. 2015;63:119-24. https://doi.org/10.1016/j.indcrop.2014.10.022.

  • 26.

    Durán N, Marcato PD, De Souza GIH, Alves OL, Esposito E. Antibacterial effect of silver nanoparticles produced by fungal process on textile fabrics and their effluent treatment. J Biomed Nanotechnol. 2007;3(2):203-8. https://doi.org/10.1166/jbn.2007.022.

  • 27.

    Wiley BJ, Im SH, Li ZY, McLellan J, Siekkinen A, Xia Y. Maneuvering the surface plasmon resonance of silver nanostructures through shape-controlled synthesis. J Phys Chem B. 2006;110(32):15666-75. [PubMed ID: 16898709]. https://doi.org/10.1021/jp0608628.

  • 28.

    Akhavan M, Jahangiri S, Shafaghat A. Studies on the antioxidant and antimicrobial activity and flavonoid derivatives from the fruit of Trigonosciadium brachytaenium (Boiss.) Alava. Industrial Crops and Products. 2015;63:114-8. https://doi.org/10.1016/j.indcrop.2014.10.023.

  • 29.

    Kasthuri J, Veerapandian S, Rajendiran N. Biological synthesis of silver and gold nanoparticles using apiin as reducing agent. Colloids Surf B Biointerfaces. 2009;68(1):55-60. [PubMed ID: 18977643]. https://doi.org/10.1016/j.colsurfb.2008.09.021.

  • 30.

    Ferraz ABF, Limberger RP, Bordignon SAL, von Poser GL, Henriques AT. Essential oil composition of sixHypericum species from southern Brazil. Flav Frag J. 2005;20(3):335-9. https://doi.org/10.1002/ffj.1435.

  • 31.

    Bombardelli E, Morazzoni P. Hypericum perforatum L. Fitoterapia. 1995;66(1):43–68.

  • 32.

    Li S, Shen Y, Xie A, Yu X, Qiu L, Zhang L, et al. Green synthesis of silver nanoparticles using Capsicum annuum L. extract. Green Chem. 2007;9(8):852. https://doi.org/10.1039/b615357g.

  • 33.

    Song JY, Kim BS. Rapid biological synthesis of silver nanoparticles using plant leaf extracts. Bioprocess Biosyst Eng. 2009;32(1):79-84. [PubMed ID: 18438688]. https://doi.org/10.1007/s00449-008-0224-6.

  • 34.

    Dibrov P, Dzioba J, Gosink KK, Hase CC. Chemiosmotic mechanism of antimicrobial activity of Ag(+) in Vibrio cholerae. Antimicrob Agents Chemother. 2002;46(8):2668-70. [PubMed ID: 12121953]. [PubMed Central ID: PMC127333].